CPhI China to Launch China Pharma WeekMarch 7, 2017
CPhI & P-MEC China 2017, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters (CCCMHPIE), and co-organized by Shanghai UBM Sinoexpo, will open its doors on June 20-22, 2017 in Shanghai.
The first ever edition of “China Pharma Week” will be launched with 15 important meetings and events held in Shanghai and neighboring regions. The event covers six core themes, and forums like the 8th China-World CEO Summit, CPhI & ICSE China Innovation and Development Forum, 6th P-MEC Summit, and 2017 CPhI & P-MEC Green Pharma Summit will gather global leaders of the pharmaceutical industry.
Additionally, CCCMHPIE will select a list of the Top 100 Internationalized Companies in 2016, to raise the international recognition and influence of the most prominent global Chinese pharmaceutical enterprises.
As a world-renowned exhibition for the pharmaceutical industry, CPhI & P-MEC China encompasses the entire supply chain from APIs, fine chemical and intermediates and excipients. Through to dosage forms, preparations, natural extracts, biopharmaceuticals, contract research, pharmaceutical machinery, packaging materials, laboratory instruments, and pharmaceutical logistics. More than 2,800 exhibitors will greet over 40,000 professional visitors from more than 120 countries to sustain the business relationships that will drive tomorrow’s growth.
Rutger Oudejans, Brand Director Pharma at UBM EMEA says: “CPhI China has grown to be the single most influential meeting point for pharma suppliers and customers, and this year we are introducing CPhI China Pharma
“Week to offer an even more comprehensive and bilingual knowledge and networking platform, covering all aspects of the world’s second largest pharma market. With the Government investing heavily in R&D research, new regulations like MAH opening-up the market for contract services, an enormous ingredients sector, along with an expanding middle class, there are now many new opportunities for both domestic and international companies.”